HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis.

Abstract
Etodolac, aspirin, and placebo were evaluated for efficacy and safety in 20 patients with adult-onset active rheumatoid arthritis who entered a 12-week, double-blind, parallel-group study divided into drug titration and maintenance periods and preceded by a two-week washout period. During the maintenance period the mean daily doses of etodolac and aspirin were 319 mg and 4,701 mg, respectively. At the end of the study, patients treated with etodolac showed significant improvement from baseline values in seven of ten clinical variables, namely, painful joints, swollen joints, articular index, pain intensity, morning stiffness, and investigator's and patient's overall assessments. In patients treated with aspirin, only pain intensity was lessened significantly; in those treated with placebo, only pain intensity lessened significantly and only the patient's overall assessment improved significantly. No serious side effects were noted in patients treated with etodolac. Three patients treated with aspirin were withdrawn from the study because of adverse reactions--two experienced gastrointestinal side effects and one had elevated liver enzyme levels.
AuthorsR A del Toro, R Concepción
JournalClinical therapeutics (Clin Ther) Vol. 5 Issue 4 Pg. 436-44 ( 1983) ISSN: 0149-2918 [Print] United States
PMID6223699 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Acetates
  • Anti-Inflammatory Agents
  • Etodolac
  • Aspirin
Topics
  • Acetates (adverse effects, therapeutic use)
  • Adult
  • Aged
  • Anti-Inflammatory Agents (therapeutic use)
  • Arthritis, Rheumatoid (drug therapy)
  • Aspirin (adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Etodolac
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: